Discoid Lupus Stocks List Ranked for 2024 | NYSE,

	Symbol	Grade	Name	% Change
	RIGL	B	Rigel Pharmaceuticals, Inc.	2.71
	ALDX	D	Aldeyra Therapeutics, Inc.	2.63

Related Industries: Biotechnology

Symbol	Grade	Name	Weight
QQQS	C	Invesco NASDAQ Future Gen 200 ETF	0.4
DWAS	B	PowerShares DWA SmallCap Technical Leaders Portfolio	0.29
SBIO	C	ALPS Medical Breakthroughs ETF	0.17
IWC	B	iShares Microcap ETF	0.15
FSCC	B	Trust Federated Hermes MDT Small Cap Core ETF	0.07

Compare ETFs

Date	Stock	Title
Nov 19	ALDX	ALDX Up as FDA Accepts Resubmitted NDA for Eye Drug Reproxalap
Nov 19	RIGL	How Much Upside is Left in Rigel (RIGL)? Wall Street Analysts Think 28.28%
Nov 19	RIGL	Zacks.com featured highlights Rigel, Synchrony Financial, SkyWest, Allient and Rush Street Interactive
Nov 18	RIGL	5 Relative Price Strength Options Available for Investors
Nov 18	ALDX	Aldeyra announces FDA acceptance of resubmitted reproxalap application
Nov 18	ALDX	Aldeyra Therapeutics Announces FDA Acceptance for Review of Reproxalap New Drug Application for the Treatment of Dry Eye Disease, Expands AbbVie Option Agreement
Nov 15	RIGL	Exploring Three High Growth Tech Stocks in the United States

Discoid Lupus: Discoid lupus erythematosus (DLE) is a chronic skin condition that causes a red, scaly rash on the face, scalp, and other areas of the body that are exposed to the sun. It is a type of lupus, an autoimmune disorder in which the body's immune system mistakenly attacks healthy tissue. DLE is the most common type of lupus, and it is not life-threatening. Treatment typically involves topical and oral medications, as well as lifestyle changes.